About Noxilizer
Noxilizer is an Industrial Goods & Manufacturing company based in Baltimore (United States) founded in 2004. Sterilization and decontamination equipment is manufactured for medical applications. Noxilizer has raised $36.45 million across 7 funding rounds from investors including VisionTech Partners and NewVale Capital. Noxilizer offers products and services including Nitrogen Dioxide Sterilization Equipment and Contract Sterilization Services. Its focus areas include Healthcare and Medical Products Manufacturing Machinery. Its legal entity is Noxilizer, Inc.
Company details
Noxilizer was established in 2004 in Baltimore, United States, as a provider of sterilization and decontamination solutions. Equipment designed for healthcare, pharmaceutical, and industrial uses is produced by the company. Operations center on the development and distribution of NO2-based systems for safe, low-temperature processing. The headquarters remain in Baltimore, with a focus on regulatory-compliant technologies accessible via noxilizer.com.
- Headquarters Baltimore, United States
- SectorsIndustrial Goods & Manufacturing
- Email••••••••
- Website noxilizer.com
- Social LinkedIn X Facebook
- Legal Name Noxilizer, Inc
- Total Equity Funding$36.45M (USD)
in 7 rounds
- Latest Funding Round$30M (USD), Series C
Sep 2025
- InvestorsVisionTech Partners
& 1 more
Products & Services of Noxilizer
Noxilizer offers a comprehensive portfolio of products and services, including Nitrogen Dioxide Sterilization Equipment and Contract Sterilization Services.
Equipment for ultra-low temperature sterilization is provided to pharmaceutical and medical device manufacturers to ensure effective processing of sensitive products.
Sterilization services are offered for applications such as prefilled syringes and implants, focusing on maintaining product safety and efficiency in the supply chain.
Funding Insights of Noxilizer
Noxilizer has successfully raised a total of $36.45M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.45M
- Total Rounds 7
- Last Round Series C — $30M
- First Round $3.59M
(Oct 2008)
- Investors Count 2
All 7 funding rounds of Noxilizer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $30M | Series C | – | NewVale Capital | – |
| Sep 2013 | Series B | – | – | – | |
| Jun 2013 | Series B | – | – | ||
| Oct 2010 | $775,000 | Series A | – | – | – |
| Jul 2010 | $145,000 | Series A | – | – | – |
| Mar 2010 | $1.94M | Series A | – | – | – |
| Oct 2008 | $3.59M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Noxilizer
Noxilizer has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include VisionTech Partners and NewVale Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startup investments are facilitated by VisionTech Partners. | visiontech-partners.com | United States | ||
NewVale Capital is focused on life sciences investment. | newvalecapital.com |
Investor details for Noxilizer
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Noxilizer
8 people are tracked at Noxilizer (7 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Charles Immel | Director | Board & advisors |
Stephen Schaefer | Director | Board & advisors |
Jack K. Ahrens, II | Director | Board & advisors |
John L. Brooks, III | Director | Board & advisors |
Mathias W. Samuel | Director | Board & advisors |
Alfred R. Berkeley, III | Director | Board & advisors |
Edward Miller | Director | Board & advisors |
Lawrence Bruder | Executive Chairman | Team |
Complete people profiles for Noxilizer
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Noxilizer
3 dated milestones of Noxilizer across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Noxilizer is founded.
- Funding First funding round of $3.6M.
- Funding Latest funding round, Series C, of $30.0M.
Web traffic of Noxilizer
The website of Noxilizer (noxilizer.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 25.5% vs previous month
Top companies in Medical Manufacturing Machinery
3 companies that operate in the same segment as Noxilizer (Medical Manufacturing Machinery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Customized HMI products including switches and joysticks are manufactured. | 1952 | Vista, California, United States | ||||
Health equipment is manufactured by IDEX in the United States. | 1988 | Northbrook, Illinois, United States | USD 3.46 B | 9,000 | ||
Injection moulding machines are manufactured by Engel for industrial applications. | 1945 | York, Pennsylvania, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Noxilizer
Noxilizer was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Noxilizer is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Noxilizer is a funded company, having raised a total of $36.45M across 7 funding rounds to date. The company's 1st funding round was a Series A of $3.59M, raised on Oct 2008.
Noxilizer was established in 2004 in Baltimore, United States, as a provider of sterilization and decontamination solutions. Equipment designed for healthcare, pharmaceutical, and industrial uses is produced by the company. Operations center on the development and distribution of NO2-based systems for safe, low-temperature processing. The headquarters remain in Baltimore, with a focus on regulatory-compliant technologies accessible via noxilizer.com.
Noxilizer offers Nitrogen Dioxide Sterilization Equipment and Contract Sterilization Services.
Noxilizer has 2 investors. Key investors include VisionTech Partners, and NewVale Capital.
Noxilizer operates through Noxilizer, Inc.